Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Karlsruhe, Karlsruher Institut für Technologie (KIT), Dissertation, 2020
- Ereignis
-
Veröffentlichung
- (wo)
-
Karlsruhe
- (wer)
-
KIT-Bibliothek
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Cato, A.
- DOI
-
10.5445/IR/1000129434
- URN
-
urn:nbn:de:101:1-2022080305010311978994
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuznik, Nane
- Cato, A.
- KIT-Bibliothek
Entstanden
- 2022
Ähnliche Objekte (12)
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
IKappaB-kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
IKappaB-kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
Lestaurtinib inhibits histone phosphorylation and androgen-dependent gene expression in prostate cancer cells
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Three microRNAs synergistically repress androgen receptor signaling and are downregulated in prostate carcinoma
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
IKappaB-kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines